ADGM ADGM
Company Profile ↓Company Overview
ADGM (ADGM) is a publicly traded company listed on with a market capitalization of $16.44M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -100.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -100.00% |
Stock Price Performance
| 1 Year: | -45.90% |
| 6 Months: | -27.55% |
| 3 Months: | -24.59% |
| 1 Month: | +20.75% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)63.74 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 68.7% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.00K | 26.00K | 254.00K | 132.00K | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | 253.00K | 342.00K | 31.00K | 58.00K | 0 |
| Gross Profit | - | - | - | - | -253.00K | -342.00K | -31.00K | -58.00K | 0 |
| Operating Expenses | - | - | - | - | 7.14M | 4.38M | 5.69M | 3.91M | 5.20M |
| Operating Income | -9.08M | -8.81M | -6.66M | -4.42M | -7.40M | -4.72M | -5.72M | -3.97M | -5.20M |
| EBITDA | - | - | - | - | -6.78M | -2.96M | -9.18M | -2.29M | -6.01M |
| Interest Expense | - | - | - | - | 662.00K | 720.00K | 749.00K | 775.00K | 778.00K |
| Pretax Income | - | - | - | - | -7.71M | -3.95M | -10.12M | -3.31M | -7.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - |
| Net Income | -10.76M | -8.02M | -5.73M | 3.61M | -7.71M | -3.95M | -10.12M | -3.31M | -7.00M |
| Diluted EPS | -14.15 | -10.28 | -7.35 | 0.02 | -0.51 | -0.35 | -0.66 | -0.21 | -0.31 |
| R&D Expense | 4.42M | 3.47M | 2.87M | 1.22M | 3.66M | 1.97M | 2.77M | - | 2.74M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 270.00K | 189.00K | 300.00K | 0 |
| Cost of Revenue | 1.16M | 875.00K | 1.31M | 684.00K |
| Gross Profit | -888.00K | -686.00K | -1.01M | -684.00K |
| Operating Expenses | 19.76M | 23.23M | 26.94M | 21.21M |
| Operating Income | -20.64M | -23.91M | -27.94M | -21.89M |
| EBITDA | -19.60M | -23.04M | -35.95M | -21.21M |
| Interest Expense | 0 | 137.00K | 1.66M | 2.91M |
| Pretax Income | -19.94M | -23.67M | -38.15M | -25.08M |
| Tax Provision | - | - | - | - |
| Net Income | -19.94M | -23.67M | -38.15M | -25.08M |
| Diluted EPS | -1.49 | -1.77 | -2.85 | -1.51 |
| R&D Expense | - | - | 15.40M | 10.64M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Jul 2024 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | 8.70M | 6.83M | - | 48.45M | 43.25M |
| Current Assets | - | 6.73M | 5.18M | - | 25.35M | 20.08M |
| Cash & Equivalents | - | 5.55M | 1.38M | - | 20.59M | 17.11M |
| Inventory | - | 367.00K | 3.32M | - | 2.57M | 1.67M |
| Receivables | - | 0 | 71.00K | - | 35.00K | 0 |
| Total Liabilities | - | 104.57M | 138.85M | - | 28.54M | 30.85M |
| Current Liabilities | - | 12.97M | 47.18M | - | 7.76M | 8.23M |
| Long Term Debt | - | - | 143.00K | - | 16.08M | 21.04M |
| Total Debt | - | 9.80M | 38.40M | - | 16.27M | 21.76M |
| Total Equity | - | -95.88M | -132.02M | -148.31M | 19.91M | 12.40M |
| Shares Outstanding | - | 13.39M | 14.54M | - | 15.20M | 22.21M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -19.31M | -22.41M | -25.65M | -19.01M |
| Investing Cash Flow | -1.27M | -500.00K | -340.00K | -374.00K |
| Financing Cash Flow | 130.00K | 9.53M | 21.88M | 16.13M |
| Capital Expenditure | -1.27M | -502.00K | -340.00K | -374.00K |
| Free Cash Flow | -20.58M | -22.91M | -25.99M | -19.39M |
| Net Change in Cash | -20.45M | -13.39M | -4.12M | -3.25M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | -328.9% | -363.0% | -335.3% | - |
| Operating Margin % | -7,646.3% | -12,652.4% | -9,314.0% | - |
| Net Margin % | -7,384.4% | -12,525.4% | -12,715.3% | - |
| ROE % | - | 24.7% | 28.9% | -202.3% |
| ROCE % | - | 559.9% | 69.2% | -62.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ADGM
ADGM stock surges as investors react to next-generation ULTA milestone - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQM1lRdlFCbF81c3FRQWota1FvZ3hNV0QyMjd3OTJPQlp0TGl2TUNSSUVmMllwdHZocExUclRFbl9pTkxiY0d6bXVYeHRKTkJTS25rYjU0UjR5cVFoUmdyQzlydnF1WlFnenVQdzBoWkpIQ3pMSTZzR0hZZHlQWDhha0k2ZFVteWtGc2hhMm…
Market Movers | Winners: AMIX, ADGM, IBTA | Losers: NXTT, AHCO, BETR - Trefis
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1VwNGVzZFp0SVBfV29LVUplNFVIRmQ5RUQ1TVJ4cnU1YWVLbUNSX0lqbUJiV2FUQTIxR1dVZjl2bUlkSGN2enMzX1l1MVF0VFk2cTB0cjBaSVd4ejgtZjRINnBYMkRPdTJpbEZCTFo0amlNbkNqTWJua3NpRjNUbjcyeE5CU0tZQ3hKdn…
Adagio Medical Stock Is Trending Overnight: Here's Why ADGM Jumped 22% After Hours - Benzinga
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQRXFQNklhZk96ZWp0cFY4bTZZdHExV2p4YkpDWkZjX0dWYzdLWWZQaU5QdDUxMFoyNEp3MnBnYzlTTnJYZmtFcjNpeWNrX3N2dllUX1ZDSVJQcE5TLThoSUNvSTJRWFFPT2l6STFvckZRUUN4QVNjZjZsMS00cnFDa2Ixck9FLVkzVXdFSH…
After failed ablations, patient remains VT-free ~2 months after Adagio treatment - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxON3dGU2pETWg1Z3RWME53VWRtemJucXBhYTRlZ21fbGJfTk9KWlFIRWE2V1RLMGk4Mlo5YXJCcU5xd2U5LUxUR3JQa3VWQjZHSlkwV1hKNVZwN0V6LXlIVUljTlZidDcwMGR0d3Z4NU1Pd2ZhLWV4N3dxdE9VbkVkeFYxZWVURDVlaWFDST…
Ondo Tokenized Stocks Win Abu Dhabi Approval on Binance - CoinMarketCap
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNWHNhRzVSZmYwU3FlaGw5aDJlaHVZd0l3RnJVVDNySHVxSFJUWGl0dFpqbG8zNWpyZUROcmxmUUtKT2IyU2JhLXFyN251ci1USEJhMUl3OVEzMVllR3VMSjV3bzZzTXBUbnFjazRZejNwR01NblNkakNtVHZWTzRKbmFNZ2NDOHFsUDdPWH…
ADGM - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTFBBOVVyQjByNm5NeWdBbXFHckFnZkNLMThwVVNFYXh3MXhoNThMYXB4dkZoNVZtdGVlc0ppMEdQOC1qMThkcGc?oc=5" target="_blank">ADGM</a> <font color="#6f6f6f">Finviz</font>…
ADGM — Frequently Asked Questions
What is the current share price of ADGM?
As of 2026-08-05 17:25 PDT, ADGM trades at $0.74 on NASDAQ/NYSE. Its 52-week range is $0.38 to $2.36.
What is the market capitalisation of ADGM?
ADGM has a market capitalisation of $16.44M on NASDAQ/NYSE.
What is the P/E ratio of ADGM?
ADGM trades at a trailing price-to-earnings (P/E) ratio of -0.49. Its price-to-book (P/B) ratio is 1.33.
Is ADGM a good stock to buy?
This page provides a data-driven analysis of ADGM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.